JEAN JACQUES BIENAIME Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEAN JACQUES BIENAIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of JEAN JACQUES BIENAIME for May 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 25 2018 | VTL | VITAL THERAPIES IN ... | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 6.10 | 29,538 | 180,182 | 29,538 | |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 0 | |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.66 | 18,750 | 1,662,356 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 18 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 17 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 18,750 | |
| May 17 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.13 | 18,750 | 1,671,131 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 17 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 37,500 | |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 56,250 | |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.29 | 18,750 | 1,655,434 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.22 | 18,750 | 1,672,851 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 16 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 75,000 | |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 93,750 | |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.42 | 18,750 | 1,657,856 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.59 | 18,750 | 1,679,794 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 68.78 | 309 | 21,254 | 290,600 | 290.3 K to 290.6 K (+0.11 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 75,000 | |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 18,750 | 723,563 | 93,750 | |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.42 | 18,750 | 1,657,856 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.59 | 18,750 | 1,679,794 | 290,600 | 309.4 K to 290.6 K (-6.06 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 18,750 | 723,563 | 309,350 | 290.6 K to 309.4 K (+6.45 %) |
| May 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 68.78 | 309 | 21,254 | 290,600 | 290.3 K to 290.6 K (+0.11 %) |
| May 03 2018 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | A | 60.85 | 15,000 | 912,750 | 15,000 |